Concise Definitive Review for Reinitiation of Antidepressants, Antipsychotics, and Gabapentinoids in ICU Patients
- 5 January 2022
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 50 (4), 665-673
- https://doi.org/10.1097/ccm.0000000000005415
Abstract
Objective: Concise definitive review of the reinitiation of prior-to-admission neuropsychiatric medications (NPMs) in ICU patients. Data Sources: Available literature on PubMed and MEDLINE databases. Study Selection: Available clinical trials and observational studies addressing the reinitiation of select NPMs (antidepressants, antipsychotics, and gabapentinoids) on various outcomes were included. Data Extraction: Eligible studies were identified by authors, and recommendations were summarized. Data Synthesis: Agitation and delirium are recognized as common complications of patients in the ICU. While there is literature that suggests patients can acutely withdraw from opioids, less data are known about withdrawal from NPM such as antidepressants, antipsychotics, and gabapentinoids. However, there is some literature that suggests reinitiating some NPMs may lead to reductions in agitation, delirium, and hospital and ICU length of stay. Conclusions: Additional larger studies are needed to evaluate the safety and efficacy of reinitiation of select prior-to-admission NPM to prevent agitation and delirium in ICU patients. Multiple factors for NPM reinitiation should be considered, such as reason for admission, organ dysfunction, available route of administration to provide prior-to-admission NPM, concomitant additional medications for agitation and delirium, and safety of these medications for patients in the ICU.This publication has 23 references indexed in Scilit:
- A comparative review of escitalopram, paroxetine, and sertralineInternational Clinical Psychopharmacology, 2014
- Leveraging a Critical Care DatabaseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2014
- Medication absorption considerations in patients with postpyloric enteral feeding tubesAmerican Journal of Health-System Pharmacy, 2014
- Gabapentin Withdrawal: Case Report in an Older Adult and Review of the LiteratureJournal of the American Geriatrics Society, 2013
- Withdrawal symptoms after gabapentin discontinuationAmerican Journal of Health-System Pharmacy, 2010
- The Parkinsonism-Hyperpyrexia SyndromeNeurocritical Care, 2008
- Delirium following abrupt discontinuation of fluoxetineClinical Neurology and Neurosurgery, 2008
- The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicityQJM: An International Journal of Medicine, 2003
- TrazodoneDrugs & Aging, 1994
- Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiologyActa Psychiatrica Scandinavica, 1988